ACSL4 and breast carcinoma: Further investigation revealed that compound 8 could induce ferroptosis in MCF-7 cells by downregulating the expression of ferroptosis-related genes such as ACSL4 and could combat breast cancer drug resistance by inhibiting ACSL4 protein expression.